Bayesian model-averaged benchmark dose analysis via reparameterized quantal-response models

Q. Fang, Walter W Piegorsch, S. J. Simmons, X. Li, C. Chen, Y. Wang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

An important objective in biomedical and environmental risk assessment is estimation of minimum exposure levels that induce a pre-specified adverse response in a target population. The exposure points in such settings are typically referred to as benchmark doses (BMDs). Parametric Bayesian estimation for finding BMDs has grown in popularity, and a large variety of candidate dose-response models is available for applying these methods. Each model can possess potentially different parametric interpretation(s), however. We present reparameterized dose-response models that allow for explicit use of prior information on the target parameter of interest, the BMD. We also enhance our Bayesian estimation technique for BMD analysis by applying Bayesian model averaging to produce point estimates and (lower) credible bounds, overcoming associated questions of model adequacy when multimodel uncertainty is present. An example from carcinogenicity testing illustrates the calculations.

Original languageEnglish (US)
Pages (from-to)1168-1175
Number of pages8
JournalBiometrics
Volume71
Issue number4
DOIs
StatePublished - Dec 1 2015

Fingerprint

Benchmark Dose
Benchmarking
Bayesian Model
Dose-response
Bayesian Estimation
dosage
dose response
Bayesian Model Averaging
Parametric Estimation
Target
Multi-model
Bayes Theorem
Point Estimate
Health Services Needs and Demand
Prior Information
Risk Assessment
carcinogenicity
Model
Uncertainty
environmental assessment

Keywords

  • Bayesian BMDL
  • Benchmark analysis
  • Dose-response analysis
  • Hierarchical modeling
  • Model uncertainty
  • Multimodel inference
  • Quantitative risk assessment

ASJC Scopus subject areas

  • Applied Mathematics
  • Statistics and Probability
  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Bayesian model-averaged benchmark dose analysis via reparameterized quantal-response models. / Fang, Q.; Piegorsch, Walter W; Simmons, S. J.; Li, X.; Chen, C.; Wang, Y.

In: Biometrics, Vol. 71, No. 4, 01.12.2015, p. 1168-1175.

Research output: Contribution to journalArticle

Fang, Q. ; Piegorsch, Walter W ; Simmons, S. J. ; Li, X. ; Chen, C. ; Wang, Y. / Bayesian model-averaged benchmark dose analysis via reparameterized quantal-response models. In: Biometrics. 2015 ; Vol. 71, No. 4. pp. 1168-1175.
@article{bf215b6d418c4db58c7013d0b307e994,
title = "Bayesian model-averaged benchmark dose analysis via reparameterized quantal-response models",
abstract = "An important objective in biomedical and environmental risk assessment is estimation of minimum exposure levels that induce a pre-specified adverse response in a target population. The exposure points in such settings are typically referred to as benchmark doses (BMDs). Parametric Bayesian estimation for finding BMDs has grown in popularity, and a large variety of candidate dose-response models is available for applying these methods. Each model can possess potentially different parametric interpretation(s), however. We present reparameterized dose-response models that allow for explicit use of prior information on the target parameter of interest, the BMD. We also enhance our Bayesian estimation technique for BMD analysis by applying Bayesian model averaging to produce point estimates and (lower) credible bounds, overcoming associated questions of model adequacy when multimodel uncertainty is present. An example from carcinogenicity testing illustrates the calculations.",
keywords = "Bayesian BMDL, Benchmark analysis, Dose-response analysis, Hierarchical modeling, Model uncertainty, Multimodel inference, Quantitative risk assessment",
author = "Q. Fang and Piegorsch, {Walter W} and Simmons, {S. J.} and X. Li and C. Chen and Y. Wang",
year = "2015",
month = "12",
day = "1",
doi = "10.1111/biom.12340",
language = "English (US)",
volume = "71",
pages = "1168--1175",
journal = "Biometrics",
issn = "0006-341X",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Bayesian model-averaged benchmark dose analysis via reparameterized quantal-response models

AU - Fang, Q.

AU - Piegorsch, Walter W

AU - Simmons, S. J.

AU - Li, X.

AU - Chen, C.

AU - Wang, Y.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - An important objective in biomedical and environmental risk assessment is estimation of minimum exposure levels that induce a pre-specified adverse response in a target population. The exposure points in such settings are typically referred to as benchmark doses (BMDs). Parametric Bayesian estimation for finding BMDs has grown in popularity, and a large variety of candidate dose-response models is available for applying these methods. Each model can possess potentially different parametric interpretation(s), however. We present reparameterized dose-response models that allow for explicit use of prior information on the target parameter of interest, the BMD. We also enhance our Bayesian estimation technique for BMD analysis by applying Bayesian model averaging to produce point estimates and (lower) credible bounds, overcoming associated questions of model adequacy when multimodel uncertainty is present. An example from carcinogenicity testing illustrates the calculations.

AB - An important objective in biomedical and environmental risk assessment is estimation of minimum exposure levels that induce a pre-specified adverse response in a target population. The exposure points in such settings are typically referred to as benchmark doses (BMDs). Parametric Bayesian estimation for finding BMDs has grown in popularity, and a large variety of candidate dose-response models is available for applying these methods. Each model can possess potentially different parametric interpretation(s), however. We present reparameterized dose-response models that allow for explicit use of prior information on the target parameter of interest, the BMD. We also enhance our Bayesian estimation technique for BMD analysis by applying Bayesian model averaging to produce point estimates and (lower) credible bounds, overcoming associated questions of model adequacy when multimodel uncertainty is present. An example from carcinogenicity testing illustrates the calculations.

KW - Bayesian BMDL

KW - Benchmark analysis

KW - Dose-response analysis

KW - Hierarchical modeling

KW - Model uncertainty

KW - Multimodel inference

KW - Quantitative risk assessment

UR - http://www.scopus.com/inward/record.url?scp=84955337281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955337281&partnerID=8YFLogxK

U2 - 10.1111/biom.12340

DO - 10.1111/biom.12340

M3 - Article

VL - 71

SP - 1168

EP - 1175

JO - Biometrics

JF - Biometrics

SN - 0006-341X

IS - 4

ER -